http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-76797-A3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_634715a790f7ef0163a61e9f364bebcd |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 |
filingDate | 1995-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06eb271a19ce73354913fffea14760e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c093a1f111d609dee39caf23f0cecb2 |
publicationDate | 1998-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | SK-76797-A3 |
titleOfInvention | Therapeutic preparation for inhalation containing parathyroid hormone, pth |
abstract | The present invention relates to compositions and methods for pulmonary administration of full-length parathyroid hormone to mammalian hosts for the treatment of osteoporosis. Thus there is provided a therapeutic, dry powder preparation suitable for inhalation comprising (i) as an active substance, a parathyroid hormone having an amino acid sequence which is at least 90% homologous to the sequence shown as SEQ ID NO: 1 in the Sequence Listing having the biological activities of the full-length parathyroid hormone; (ii) a pharmaceutically acceptable carrier consisting of coarse particles; and, optionally, (iii) as an active substance, a substance which enhances the absorption of parathyroid hormone in the lower respiratory tract; wherein an ordered mixture is formed between said active compound(s) and the carrier; in which at least 50% of the total mass of the active substance parathyroid hormone consists of (a) particles having a diameter of up to 10 microns; or (b) agglomerates of such particles. <IMAGE> |
priorityDate | 1994-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 965.